Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.040
-0.040 (-1.92%)
At close: Sep 11, 2026, 4:00 PM EDT
2.000
-0.040 (-1.96%)
After-hours: Sep 11, 2026, 7:31 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $9.03 million as of September 11, 2026. Its market cap has decreased by -92.94% in one year.
Market Cap
9.03M
Enterprise Value
-852.94K
1-Year Change
-92.94%
Ranking
Category
Stock Price
$2.04
ChartMarket Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $9.03M, a decrease of -97.46%. That is a compound annual growth rate of -78.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 9.00M | -62.50% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 9.74M |
| Senti Biosciences Holdings | 9.53M |
| Ensysce Biosciences | 9.47M |
| CytoMed Therapeutics | 9.25M |
| Exicure | 9.16M |
| Xenetic Biosciences | 9.14M |
| Traws Pharma | 8.67M |
| CNS Pharmaceuticals | 8.53M |